↓ Skip to main content

Targeting wild-type Erythrocyte receptors for Plasmodium falciparum and vivax Merozoites by Zinc Finger Nucleases In- silico: Towards a Genetic Vaccine against Malaria

Overview of attention for article published in Genetic Vaccines and Therapy, August 2012
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
1 X user
googleplus
1 Google+ user

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
20 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Targeting wild-type Erythrocyte receptors for Plasmodium falciparum and vivax Merozoites by Zinc Finger Nucleases In- silico: Towards a Genetic Vaccine against Malaria
Published in
Genetic Vaccines and Therapy, August 2012
DOI 10.1186/1479-0556-10-8
Pubmed ID
Authors

Henry Kajumbula, Wilson Byarugaba, Misaki Wayengera

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 20 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 5%
Unknown 19 95%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 3 15%
Student > Master 3 15%
Student > Postgraduate 3 15%
Other 2 10%
Student > Ph. D. Student 1 5%
Other 3 15%
Unknown 5 25%
Readers by discipline Count As %
Agricultural and Biological Sciences 5 25%
Medicine and Dentistry 4 20%
Biochemistry, Genetics and Molecular Biology 2 10%
Nursing and Health Professions 1 5%
Pharmacology, Toxicology and Pharmaceutical Science 1 5%
Other 1 5%
Unknown 6 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 October 2023.
All research outputs
#14,649,143
of 24,567,524 outputs
Outputs from Genetic Vaccines and Therapy
#38
of 45 outputs
Outputs of similar age
#100,687
of 175,897 outputs
Outputs of similar age from Genetic Vaccines and Therapy
#3
of 3 outputs
Altmetric has tracked 24,567,524 research outputs across all sources so far. This one is in the 39th percentile – i.e., 39% of other outputs scored the same or lower than it.
So far Altmetric has tracked 45 research outputs from this source. They receive a mean Attention Score of 4.5. This one scored the same or higher as 7 of them.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 175,897 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 41st percentile – i.e., 41% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 3 others from the same source and published within six weeks on either side of this one.